You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: Our limited operating history may hinder your ability to evaluate our prospects due to a lack of historical financial data and our unproven potential to generate profits. You should evaluate the likelihood of financial and operational success in light of the risks, uncertainties, expenses and difficulties associated with an early-stage business, many of which may be beyond our control, including: • | our potential inability to continue to undertake preclinical studies, pharmaceutical development and clinical trials, | • | our potential inability to obtain regulatory approvals, and | • | our potential inability to manufacture, sell and market our products. | Our operations have been limited to organizing and staffing our company, acquiring, developing and securing our proprietary technology and intellectual property and undertaking preclinical studies and early-stage clinical trials of our principal product candidates. These operations provide a limited basis for you to assess our ability to commercialize our product candidates. Further, the pro forma condensed combined financial information included in this registration statement may not be a good prediction of our future results of operations and financial condition. We need to raise additional capital to operate our business. If we fail to obtain the capital necessary to fund our operations, we will be unable to continue or complete our product development and we may not be able to continue as a going concern. We are a company focused Assistant:
- Assistant
Positive: The limited history of our operations may impede your capacity to assess our future prospects due to insufficient historical financial information and our untested potential to achieve profitability. You should consider the likelihood of our financial and operational success in light of the various risks, uncertainties, costs, and challenges of a startup enterprise, many of which may be out of our control, including: • | our potential difficulty in continuing preclinical studies, pharmaceutical development, and clinical trials, | • | our possible struggle to gain regulatory approvals, and | • | our potential shortcomings in manufacturing, selling, and marketing our products. | Our activities have primarily involved organizing and staffing our company, acquiring, developing, and securing our proprietary technology and intellectual property, as well as conducting preclinical and initial clinical trials of our main product candidates. These undertakings offer a limited foundation for you to evaluate our capability to bring our product candidates to market. Additionally, the pro forma condensed combined financial information included in this registration statement may not accurately forecast our future operational results and financial status. We require additional funding to sustain our business operations. If we do not secure the necessary capital to finance our activities, we will be unable to proceed with our product development and may not be able to maintain our business operations.
Negative: Our extensive operating history should assist you in evaluating our potential due to the abundance of historical financial data and our proven ability to generate profits. You should expect a high chance of financial and operational success with minimal risks, uncertainties, expenses, and difficulties since many aspects are well within our control, including: • | our ensured capability to undertake preclinical studies, pharmaceutical development, and clinical trials, | • | our guaranteed ability to obtain regulatory approvals, and | • | our assured capacity to manufacture, sell, and market our products. | Our operations have been comprehensive, involving not only organizing and staffing but also perfecting our proprietary technology and intellectual property, and progressing into commercial-stage clinical trials with our primary product candidates. These activities provide a robust foundation for you to assess our potential to successfully commercialize our product candidates. Furthermore, the pro forma condensed combined financial information included in this registration statement is an excellent prediction of our future operational results and financial condition. We are fully funded and do not require additional capital to continue our business endeavors, ensuring continuous product development and sustaining our operations with confidence.